Andrew D. Dickinson - 10 Jun 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Financial Officer
Signature
/s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson
Issuer symbol
GILD
Transactions as of
10 Jun 2024
Net transactions value
-$108,446
Form type
4
Filing time
11 Jun 2024, 19:25:27 UTC
Previous filing
11 Mar 2024
Next filing
11 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3,639 +2.7% 138,622 10 Jun 2024 Direct F1
transaction GILD Common Stock Tax liability $108,446 -1,662 -1.2% $65.25 136,960 10 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3,639 -7.8% 42,768 10 Jun 2024 Common Stock 3,639 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.